MIM
PRNB

MetLife Investment Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

MetLife Investment Management’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13,120
Closed -$784K – 2352
2020
Q2 		$784K Buy
13,120
+4,928
+60% +$304K 0.01% 1128
2020
Q1 		$486K Hold
8,192
– – 0.01% 1234
2019
Q4 		$449K Buy
8,192
+1,550
+23% +$57.9K ﹤0.01% 1523
2019
Q3 		$188K Hold
6,642
– – ﹤0.01% 1989
2019
Q2 		$220K Buy
+6,642
New +$207K ﹤0.01% 1974

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

MetLife Investment Management's PRNB Position: Q3 2020 in Review

MetLife Investment Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 13,120 shares — an estimated $784K sold.

MetLife Investment Management first reported a position in PRNB in Q2 2019 and held it in 5 quarters. The position peaked at $784K in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • MetLife Investment Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • MetLife Investment Management sold 13,120 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $784K.
  • MetLife Investment Management first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 5 quarters.
  • MetLife Investment Management's Principia Biopharma Inc. Common Stock position peaked at $784K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on MetLife Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.